Malaysian Biotechnology Corporation, Universiti Malaysia Pahang and Evolva collaborate to establish centre of excellence for Malaysian Natural Products

Focus on Biosynthesis of High Value Indigenous Malaysian Natural Products

Evolva Holding SA (SIX: EVE) announced that it will collaborate with Universiti Malaysia Pahang (UMP) to establish a scientific Centre of Excellence for natural products from Malaysia as part of the Flavor and Fragrance Cluster in the state of Pahang.

The Centre of Excellence, which is being facilitated by the Malaysian Biotechnology Corporation (BiotechCorp), under Malaysia’s flagship Bioeconomy Transformation Programme, Bio-Accelerators for Technology Development and Innovation, will focus on the development of natural compounds using Evolva’s yeast fermentation production platform. The goal is to create a new paradigm in the sustainable production of Malaysia’s high value indigenous natural products.

“Malaysia has abundant natural products with high potential to be developed into high purity as well as active ingredients for the cosmetic, pharmaceutical, and other high-end industries. With Evolva’s unique platform and UMP’s research strength, the Centre is impetus in our efforts to establish the links between the science knowledge base and the business community. This will create value for other industries with significant economic opportunities to benefit Malaysia’s Bioeconomy agenda,” said BiotechCorp’s Chief Executive Officer, Dato’ Dr Mohd Nazlee Kamal.

The first programme at the Centre will focus on the production of agarwood fragrances via yeast fermentation. The development of a range of agarwood products by fermentation will allow Malaysia to significantly widen the use of agarwood worldwide, and will complement the existing traditional production approaches.

UMP Vice Chancellor, Professor Dato’ Daing Nasir Ibrahim said, “It is a privilege and honor to be able to collaborate with our two esteemed partners in the establishment of the Centre of Excellence. Our capacity building in scientific facilities and academic talents in the last two years has positioned UMP to play a meaningful role in this truly interesting partnership venture”.

Agarwood of the Aquilaria and Gyrinops variety has been prized for centuries by incense and perfume makers, and traditional medicine practitioners. More recently, agarwood has been designated as an endangered species by the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES). Despite conservation measures and concerted efforts to grow Aquilaria and Gyrinops in tree nurseries and organic tree farms, these evergreens are rapidly vanishing from forests due to high demand.

According to data collected by the Wild Trade Monitoring Network, the global supply of wild agarwood could vanish from the planet in less than two years.

Chief Executive Officer of Evolva, Neil Goldsmith said, “We are delighted to participate in this venture in Malaysia and would like to commend the efforts of BiotechCorp for facilitating this collaboration. We are looking forward to working with the passionate and talented researchers at UMP to determine if agarwood compounds might be amenable to production via biosynthesis and yeast fermentation. If successful, this Centre’s global and multi-disciplinary efforts will produce both positive economic and environmental benefits for us all.”

– Ends –

Download PDF:

Download press release in English
Download press release in German

About Evolva

Evolva is a pioneer and global leader in sustainable, fermentation-based approaches to ingredients for health, wellness and nutrition. Evolva’s products include stevia, vanilla, saffron and resveratrol. As well as developing its own proprietary ingredients, Evolva also deploys its technology for partners, providing them with a competitive edge and sharing in the returns they make. For more information see

About BiotechCorp

BiotechCorp is the lead development agency for the biotech industry in Malaysia and acts as a central contact point providing support, facilitation and advisory services for biotech and life sciences companies in Malaysia. BioNexus Status companies are international and Malaysian biotech companies that qualify for fiscal incentives, grants and guarantees administered by BiotechCorp. For further details, visit
Bioeconomy Transformation Programme (BTP) is a platform provided by the Malaysian government for the private sector to channel and maximise commercial opportunities in bio-based industries. The BTP is designed as a Transformation Programme based on biotechnology’s potential to cut across various industries and transform Malaysia into a high income, inclusive and sustainable nation. Through the BTP, Bioeconomy will benefit the society and nation through breakthroughs in agricultural productivity, discoveries in healthcare and the adoption of sustainable industrial processes, having the effect of both enriching our society and nation through wealth creation besides securing our future. For further information, visit

Contact Details

Neil Goldsmith, CEO Jakob Dynnes Hansen, CFO Paul Verbraeken, IR
+ 41 61 485 2005 + 41 61 485 2034 + 41 61 485 2035

This press release contains specific forward-looking statements, e.g. statements including terms like believe, assume, expect or similar expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may result in a substantial divergence between the actual results, financial situation, development or performance of the company and those explicitly or implicitly presumed in these statements. Against the background of these uncertainties readers should not place undue reliance on forward-looking statements. The company assumes no responsibility to update forward-looking statements or to adapt them to future events or developments.